Emmanuel S. Akinboye, Ph.D. - Publications

Affiliations: 
2012 Chemistry Howard University 
Area:
Biochemistry, Organic Chemistry, Pharmaceutical Chemistry, Oncology

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Akinboye ES, Rosen MD, Bakare O, Denmeade SR. Anticancer activities of emetine prodrugs that are proteolytically activated by the prostate specific antigen (PSA) and evaluation of in vivo toxicity of emetine derivatives. Bioorganic & Medicinal Chemistry. PMID 29153549 DOI: 10.1016/J.Bmc.2017.11.015  0.644
2016 Akinboye ES, Brennen WN, Rosen DM, Bakare O, Denmeade SR. Iterative design of emetine-based prodrug targeting fibroblast activation protein (FAP) and dipeptidyl peptidase IV DPPIV using a tandem enzymatic activation strategy. The Prostate. PMID 26835873 DOI: 10.1002/Pros.23162  0.615
2016 Akinboye ES, Brennen WN, Rosen DM, Bakare O, Denmeade SR. Iterative design of emetine-based prodrug targeting fibroblast activation protein (FAP) and dipeptidyl peptidase IV DPPIV using a tandem enzymatic activation strategy Prostate. DOI: 10.1002/pros.23162  0.577
2015 Bamji ZD, Washington KN, Akinboye E, Bakare O, Kanaan YM, Copeland RL. Apoptotic Effects of Novel Dithiocarbamate Analogs of Emetine in Prostate Cancer Cell Lines. Anticancer Research. 35: 4723-32. PMID 26254362  0.608
2015 Akinboye ES, Bamji ZD, Kwabi-Addo B, Ejeh D, Copeland RL, Denmeade SR, Bakare O. Design, synthesis and cytotoxicity studies of dithiocarbamate ester derivatives of emetine in prostate cancer cell lines. Bioorganic & Medicinal Chemistry. 23: 5839-45. PMID 26187015 DOI: 10.1016/J.Bmc.2015.06.072  0.685
2013 Brandy Y, Brandy N, Akinboye E, Lewis M, Mouamba C, Mack S, Butcher RJ, Anderson AJ, Bakare O. Synthesis and characterization of novel unsymmetrical and symmetrical 3-halo- or 3-methoxy-substituted 2-dibenzoylamino-1,4-naphthoquinone derivatives. Molecules (Basel, Switzerland). 18: 1973-84. PMID 23381023 DOI: 10.3390/Molecules18021973  0.59
2012 Akinboye ES, Rosen MD, Denmeade SR, Kwabi-Addo B, Bakare O. Design, synthesis, and evaluation of pH-dependent hydrolyzable emetine analogues as treatment for prostate cancer. Journal of Medicinal Chemistry. 55: 7450-9. PMID 22867001 DOI: 10.1021/Jm300426Q  0.647
2012 Khraiwesh MH, Lee CM, Brandy Y, Akinboye ES, Berhe S, Gittens G, Abbas MM, Ampy FR, Ashraf M, Bakare O. Antitrypanosomal activities and cytotoxicity of some novel imido-substituted 1,4-naphthoquinone derivatives. Archives of Pharmacal Research. 35: 27-33. PMID 22297740 DOI: 10.1007/S12272-012-0103-1  0.589
2011 Akinboye ES, Bakare O. Biological activities of emetine Open Natural Products Journal. 4: 8-15. DOI: 10.2174/1874848101104010008  0.635
2009 Akinboye ES, Butcher RJ, Wright DA, Brandy Y, Bakare O. N-(3-Bromo-1,4-dioxo-1,4-dihydro-2-naphth-yl)-4-fluoro-N-(4-fluoro-benzo-yl)benzamide. Acta Crystallographica. Section E, Structure Reports Online. 65: o277. PMID 21581890 DOI: 10.1107/S1600536809000117  0.728
2008 Akinboye ES, Butcher RJ, Brandy Y, Adesiyun TA, Bakare O. N-(3-Bromo-1,4-dioxo-1,4-dihydro-2-naphth-yl)-2-chloro-N-(2-chloro-benzoyl)benzamide. Acta Crystallographica. Section E, Structure Reports Online. 65: o24. PMID 21581667 DOI: 10.1107/S1600536808039214  0.73
Show low-probability matches.